These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents. Guda R; Kumar G; Korra R; Balaji S; Dayakar G; Palabindela R; Myadaraveni P; Yellu NR; Kasula M J Photochem Photobiol B; 2017 Nov; 176():69-80. PubMed ID: 28964888 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives. Khodair AI; Alsafi MA; Nafie MS Carbohydr Res; 2019 Dec; 486():107832. PubMed ID: 31622868 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase. Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors. Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents. Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876 [TBL] [Abstract][Full Text] [Related]
8. Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660 [TBL] [Abstract][Full Text] [Related]
9. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives. Mphahlele MJ; Gildenhuys S; Parbhoo N Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619 [TBL] [Abstract][Full Text] [Related]
11. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer. Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel quinazoline derivatives as immune checkpoint inhibitors. Thuy Lu Vo T; Hoang VH; Thi Phuong Dung P; Anh Chi N; Minh Huy V; Tung Ngo S; Thi Kim Nguyen Y; Thi Thu Hien T; Hoang TH; Thi Do Y; Hae Seo J; Tran PT Bioorg Med Chem Lett; 2024 Aug; 108():129796. PubMed ID: 38754563 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors. Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. Alsaid MS; Al-Mishari AA; Soliman AM; Ragab FA; Ghorab MM Eur J Med Chem; 2017 Dec; 141():84-91. PubMed ID: 29028534 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
18. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors. Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493 [TBL] [Abstract][Full Text] [Related]
19. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents. Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673 [TBL] [Abstract][Full Text] [Related]
20. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents. Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]